glp 1 and general anesthesia Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care The Impact of GLP-1 Receptor
Description
Intestinal release of GLP-1 augments initial insulin secretion in vivo in part through a vagal-vagal reflex leading to cholinergic stimulation of islet beta cells
This dose escalation strategy helps minimise gastrointestinal side effects whilst allowing the body to adapt to the medication's effects
Graham et al
Calder PC
Emerging clinical analyses indicate that medically induced weight loss may compromise skeletal muscle unless anabolic support is appropriately maintained [40]
Your doctor can evaluate hormonal status, medication interactions, and underlying conditions that may contribute to libido changes
